Dr Reddys Laboratories receives EIR report for Srikakulam formulation plant Unit II

Bs_logoImage
Capital Market
Last Updated : Sep 22 2017 | 12:02 AM IST

From USFDA

Dr Reddys Laboratories has received an Establishment Inspection Report (EIR) from the US FDA, for the Company's Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Sep 21 2017 | 10:00 AM IST